Anteris as a surgical solution will look a lot more viable to health admins when it has the backing of a multi-billion, multi-national company.
Nobody wants to sue a 300, 400, 6,7,800 $mill company, you'll only get peanuts out them.
- Forums
- ASX - By Stock
- AVR
- Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-75
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.23 |
Change
0.010(0.05%) |
Mkt cap ! $388.8M |
Open | High | Low | Value | Volume |
$20.20 | $20.28 | $20.20 | $9.995K | 494 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 810 | $20.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.74 | 20 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 810 | 20.190 |
1 | 40 | 20.180 |
1 | 40 | 20.160 |
1 | 40 | 20.140 |
1 | 10 | 20.060 |
Price($) | Vol. | No. |
---|---|---|
20.740 | 20 | 1 |
20.750 | 375 | 1 |
21.050 | 998 | 1 |
21.700 | 467 | 2 |
22.000 | 1029 | 2 |
Last trade - 10.46am 16/05/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online